FBT
First Trust NYSE Arca Biotechnology Index Fund Equity$214.10
+2.70%
(+5.62)
AUM $2.34B
Expense 55.00%
52w Low $152.78
85.0% of range
52w High $224.94
50d MA $201.71
200d MA $195.45
NAV
$208.35
AUM
$2.34B
Expense
55.00%
Holdings
30
Avg Volume
24K
Inception
Jun 19, 2006
Issuer
First Trust
Exchange
—
Domicile
US
ISIN
US33733E2037
50d MA
$201.71
200d MA
$195.45
About
The First Trust NYSE Arca Biotechnology Index Fund is an exchange-traded index fund. The investment objective of the Fund is to replicate as closely as possible, before fees and expenses, the price and yield of the NYSE Arca Biotechnology Index.
Sector Exposure
Healthcare
100.0%
Top Holdings
| Ticker | Name | Weight |
|---|---|---|
| AXSM | Axsome Therapeutics, Inc. | 4.01% |
| CORT | Corcept Therapeutics Inc. | 3.92% |
| NEO | NeoGenomics, Inc. | 3.69% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | 3.69% |
| ILMN | Illumina, Inc. | 3.69% |
| KRYS | Krystal Biotech, Inc. | 3.52% |
| BIIB | Biogen Inc. | 3.50% |
| ALKS | Alkermes Plc | 3.48% |
| NTRA | Natera, Inc. | 3.43% |
| VCYT | Veracyte, Inc. | 3.40% |
| ADMA | ADMA Biologics, Inc. | 3.39% |
| NBIX | Neurocrine Biosciences, Inc. | 3.36% |
| RGEN | Repligen Corporation | 3.35% |
| SRPT | Sarepta Therapeutics, Inc. | 3.30% |
| TECH | Bio-Techne Corporation | 3.27% |